Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
DXCM250502P56000
- 0.33
- +0.08+32.00%
15min DelayClose Apr 30 16:00 ET
0.33High0.10Low
0.10Open0.25Pre Close8 Volume38 Open Interest56.00Strike Price238.00Turnover251.70%IV22.01%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type-0.0606Delta0.0102Gamma216.30Leverage Ratio-0.3138Theta-0.0002Rho-13.12Eff Leverage0.0056Vega
DexCom Newsroom
As DexCom (NASDAQ:DXCM) Lifts 7.5% This Past Week, Investors May Now Be Noticing the Company's One-year Earnings Growth
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Unusual Options Activity: C, SCHW and Others Attract Market Bets, C V/OI Ratio Reaches 52.6
ISRG, LLY, or DXCM: Which "Strong Buy" Healthcare Stock Has the Highest Upside Potential?
Earnings Preview: DexCom to Report Financial Results Post-market on May 01
Phenomix Sciences and Mayo Clinic to Present Landmark Research at DDW 2025, Advancing Precision Obesity Medicine
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U
Express News | Shares of Diabetes Stocks Are Trading Lower Following Successful Obesity Data From Lilly
DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Express News | Diabetes Device Maker Dexcom Shares Down 3.1% Premarket After Lilly's Pill Leads to Weight Loss in Late-Stage Trial
DexCom (NasdaqGS:DXCM) Gains FDA Clearance For Dexcom G7 System
Express News | Johnson Fistel Has Commenced an Investigation on Behalf of Dexcom, Inc. Shareholders
RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $100
Wells Fargo Sticks to Its Buy Rating for Dexcom (DXCM)
BTIG Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $107
BTIG Remains a Buy on Dexcom (DXCM)
Notable Healthcare Headlines of the Week: Norvatis, Novo Nordisk, Eli Lilly in Focus
Barclays Maintains DexCom(DXCM.US) With Hold Rating, Maintains Target Price $90
Citi Maintains DexCom(DXCM.US) With Buy Rating
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $100
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now